A 72-year-old Chinese male, @entity1956 carrier, received a right hepatic trisegmentectomy in 1997 for @entity11469 . Serum @entity160 was in the normal range until two years after the operation, a rapid increase to 241 ng/mL occurred and computed tomography showed a 2-cm-sized recurrent nodule in the caudate lobe. Because computed tomography arterioportography showed additional multifocal nodules in the residual liver, transarterial embolization was performed. Four months after the first transarterial embolization, the caudate @entity5 grew to 6 cm and serum @entity160 increased to 6090 ng/mL. Prior to the second transarterial embolization, this new @entity99 received a biopsy and showed a characteristic feature of @entity157 , which was different from the previous one. Four months after the second transarterial embolization, computed tomography showed no recurrent @entity5 and serum @entity160 subsequently normalized. Twenty-two months after the first transarterial embolization, a 2.5-cm-sized @entity5 recurred again at the lateral segment. At this time, serum @entity160 (3.6 ng/mL) was not elevated. He received the third transarterial embolization and is still alive. Recurrence of @entity11469 after hepatic resection has been reported to be high, but a case report with a character of muticentric, multifocal, and metachronous recurrences of fibrolamellar and @entity157 is very rare. This is the second case report in the literature.

XXXX with a recurrence of @entity157 : a case report and review of Oriental cases.

@entity1956 :: ('MESH:D006509', 'Disease') :: ['hepatitis B'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor'] @entity11469 :: ('MESH:C537258', 'Disease') :: ['fibrolamellar hepatocellular carcinoma'] @entity160 :: ('174', 'Gene') :: ['alpha-fetoprotein'] @entity157 :: ('MESH:D006528', 'Disease') :: ['classic type hepatocellular carcinoma', 'classic hepatocellular carcinoma'] @entity99 :: ('MESH:D056486', 'Disease') :: ['hepatic lesion']
@entity11469 :: (MESH:C537258,Disease) :: ['Fibrolamellar hepatocellular carcinoma']
